Millhouse and Pharmstandard: Roman Abramovic’s investment vehicle Millhouse and the pharmaceutical company Pharmstandard are planning to buy Biocad, the biopharmaceutical company based in St Petersburg. Unconfirmed reports indicate that Millhouse will take a 50% stake and Pharmstandard 20%. BFM